Amneal Pharmaceuticals (AMRX) Current Assets (2017 - 2026)

Amneal Pharmaceuticals has reported Current Assets for 10 years, with the latest figure at $1.9 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 22.86% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 22.86% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 20.37% from the prior year.
• Current Assets was $1.9 billion for Q2 2026 at Amneal Pharmaceuticals, up from $1.8 billion in the prior quarter.
• The five-year high for Current Assets was $1.9 billion in Q2 2026, with the low at $1.3 billion in Q1 2023.
• Average Current Assets over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Assets declined 10.9% in 2022, then rose 22.86% in 2026.
• Over 5 years, Current Assets stood at $1.4 billion in 2022, then decreased by 2.41% to $1.4 billion in 2023, then increased by 15.24% to $1.6 billion in 2024, then climbed by 20.37% to $1.9 billion in 2025, then rose by 1.88% to $1.9 billion in 2026.
• The last three Current Assets figures came in at $1.9 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.